Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/14457

TDMS Study 88007-06 Pathology Tables

NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Columbus                                       SODIUM NITRITE                                    DATE: 05/13/99       
EXPERIMENT: 88007 TEST: 06                                                                                     TIME: 09:40:55       
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE                                   PAGE:       1        
CONT: NO1-ES-55384                              ROUTE: DOSED WATER                                             NTP C#: C88007       
PATHOLOGIST: TOFT, JOHN                                                                                        CAS: 7632-00-0       
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    
                                                        2 YEAR CHRONIC MICE                                                         
                                                                                                                                    

               REASONS FOR REMOVAL:    ALL                                                                                          
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
               REMOVAL DATE RANGE:     ALL                                                                                          
                                                                                                                                    
               TREATMENT GROUPS:       INCLUDE ALL                                                                                  
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08
LAB: Battelle Columbus                                       SODIUM NITRITE                                    DATE: 05/13/99

EXPERIMENT: 88007 TEST: 06                                                                                     TIME: 09:40:55
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE
CONT: NO1-ES-55384                              ROUTE: DOSED WATER                                             NTP C#: C88007
PATHOLOGIST: TOFT, JOHN                                                                                        CAS: 7632-00-0

Mice(B6C3F1)
-----------------------------
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE
BASED ON NUMBER OF TISSUES EXAMINED.  IN OTHER TISSUES/ORGANS RATES
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.
                                                 ---------------
                                                 Adrenal Medulla
                                                 Bone Marrow
                                                 Brain
                                                 Islets, Pancreatic
                                                 Kidney
                                                 Liver
                                                 Lung
                                                 Ovary
                                                 Pituitary Gland
                                                 Spleen
                                                 Testes
                                                 Thymus
                                                 Thyroid Gland
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08   
LAB: Battelle Columbus                                       SODIUM NITRITE                                    DATE: 05/13/99     
EXPERIMENT: 88007 TEST: 06                                                                                     TIME: 09:40:55     
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE                                                      
CONT: NO1-ES-55384                              ROUTE: DOSED WATER                                             NTP C#: C88007     
PATHOLOGIST: TOFT, JOHN                                                                                        CAS: 7632-00-0     



SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS
IN THE ANALYSIS OF                  SODIUM NITRITE
===============================================================

Male Mice
------------
Organ                                 Morphology
-----                                 ----------
Intestine Small: Jejunum               Carcinoma
Intestine Small: Site Unspecified      Carcinoma
Liver                                  Hepatoblastoma
                                       Hepatocellular Carcinoma or Hepatocellular Adenoma
                                       Hepatocellular Carcinoma, Hepatocellular Adenoma, or Hepatoblastoma
Lung                                   Alveolar/Bronchiolar Carcinoma or Alveolar/Bronchiolar Adenoma
All Organs                             Malignant Tumors
===============================================================
Female Mice
------------
Organ                                  Morphology
-----                                  ----------
Lung                                   Alveolar/Bronchiolar Carcinoma or Alveolar/Bronchiolar Adenoma
Skin                                   Fibrosarcoma
                                       Schwannoma Malignant
Stomach, Forestomach                   Squamous Cell Carcinoma
                                       Squamous Cell Carcinoma or Papilloma Squamous
All Organs                             Benign Tumors
                                       Malignant Tumors
                                       Malignant and Benign Tumors
===============================================================
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 1
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)        -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Bone Marrow                                                                                                                      |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    0/50 (0%)    0/49 (0%)    0/50 (0%)   |0/50 (0%)    1/50 (2%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     4.3%         0.0%         0.0%         0.0%        |0.0%         2.2%         0.0%         0.0%         |
|TERMINAL (d)       |     1/39 (3%)    0/45 (0%)    0/41 (0%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |     661          ---          ---          ---         |---          605          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.117N     P=0.222N     P=0.232N     P=0.245N    |P=0.568N     P=0.517      (e)          (e)          |
|POLY 3             |     P=0.114N     P=0.234N     P=0.239N     P=0.245N    |P=0.564N     P=0.502      (e)          (e)          |
|POLY 1.5           |     P=0.114N     P=0.236N     P=0.240N     P=0.242N    |P=0.565N     P=0.501      (e)          (e)          |
|POLY 6             |     P=0.114N     P=0.231N     P=0.239N     P=0.248N    |P=0.564N     P=0.499      (e)          (e)          |
|LOGISTIC REGRESSION|     P=0.111N     P=0.242N     P=0.254N     P=0.230N    |P=0.523N     P=0.441      (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.116N     P=0.247N     P=0.253N     P=0.247N    |P=0.567N     P=0.500      (e)          (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Harderian Gland                                                                                                                  |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     4/50 (8%)    3/50 (6%)    4/50 (8%)    1/50 (2%)   |0/50 (0%)    1/50 (2%)    0/50 (0%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     8.5%         6.2%         8.4%         2.2%        |0.0%         2.2%         0.0%         4.3%         |
|TERMINAL (d)       |     2/39 (5%)    2/45 (4%)    4/42 (10%)   1/39 (3%)   |0/40 (0%)    1/34 (3%)    0/37 (0%)    2/41 (5%)    |
|FIRST INCIDENCE    |     661          612          727 (T)      727 (T)     |---          728 (T)      ---          728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.171N     P=0.446N     P=0.606N     P=0.188N    |P=0.157      P=0.468      (e)          P=0.244      |
|POLY 3             |     P=0.173N     P=0.488N     P=0.637N     P=0.190N    |P=0.142      P=0.500      (e)          P=0.241      |
|POLY 1.5           |     P=0.167N     P=0.494N     P=0.639N     P=0.186N    |P=0.141      P=0.500      (e)          P=0.239      |
|POLY 6             |     P=0.181N     P=0.478N     P=0.637N     P=0.195N    |P=0.145      P=0.496      (e)          P=0.244      |
|LOGISTIC REGRESSION|     P=0.159N     P=0.510N     P=0.635N     P=0.185N    |(e)          P=0.468      (e)          P=0.244      |
|COCH-ARM / FISHERS |     P=0.157N     P=0.500N     P=0.643N     P=0.181N    |P=0.140      P=0.500      (e)          P=0.247      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 2
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Harderian Gland                                                                                                                  |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    2/50 (4%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    1/50 (2%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         4.2%         0.0%        |0.0%         0.0%         2.1%         0.0%         |
|TERMINAL (d)       |     0/39 (0%)    0/45 (0%)    2/42 (5%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    1/37 (3%)    0/41 (0%)    |
|FIRST INCIDENCE    |     ---          ---          727 (T)      ---         |---          ---          728 (T)      ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.588      (e)          P=0.255      (e)         |P=0.698      (e)          P=0.484      (e)          |
|POLY 3             |     P=0.574      (e)          P=0.241      (e)         |P=0.700      (e)          P=0.504      (e)          |
|POLY 1.5           |     P=0.582      (e)          P=0.240      (e)         |P=0.696      (e)          P=0.503      (e)          |
|POLY 6             |     P=0.564      (e)          P=0.242      (e)         |P=0.708      (e)          P=0.506      (e)          |
|LOGISTIC REGRESSION|     (e)          (e)          P=0.255      (e)         |(e)          (e)          P=0.484      (e)          |
|COCH-ARM / FISHERS |     P=0.595      (e)          P=0.247      (e)         |P=0.694      (e)          P=0.500      (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Harderian Gland                                                                                                                  |
|     Carcinoma or Adenoma                                                                                                        |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     4/50 (8%)    3/50 (6%)    5/50 (10%)   1/50 (2%)   |0/50 (0%)    1/50 (2%)    1/50 (2%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     8.5%         6.2%         10.5%        2.2%        |0.0%         2.2%         2.1%         4.3%         |
|TERMINAL (d)       |     2/39 (5%)    2/45 (4%)    5/42 (12%)   1/39 (3%)   |0/40 (0%)    1/34 (3%)    1/37 (3%)    2/41 (5%)    |
|FIRST INCIDENCE    |     661          612          727 (T)      727 (T)     |---          728 (T)      728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.194N     P=0.446N     P=0.540      P=0.188N    |P=0.173      P=0.468      P=0.484      P=0.244      |
|POLY 3             |     P=0.198N     P=0.488N     P=0.506      P=0.190N    |P=0.158      P=0.500      P=0.504      P=0.241      |
|POLY 1.5           |     P=0.190N     P=0.494N     P=0.504      P=0.186N    |P=0.156      P=0.500      P=0.503      P=0.239      |
|POLY 6             |     P=0.207N     P=0.478N     P=0.507      P=0.195N    |P=0.162      P=0.496      P=0.506      P=0.244      |
|LOGISTIC REGRESSION|     P=0.183N     P=0.510N     P=0.512      P=0.185N    |(e)          P=0.468      P=0.484      P=0.244      |
|COCH-ARM / FISHERS |     P=0.178N     P=0.500N     P=0.500      P=0.181N    |P=0.153      P=0.500      P=0.500      P=0.247      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 3
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Intestine Small: Duodenum                                                                                                        |
|     Polyp Adenomatous                                                                                                           |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    4/50 (8%)    3/50 (6%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     4.3%         8.4%         6.3%         0.0%        |0.0%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     2/39 (5%)    4/45 (9%)    3/42 (7%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |     727 (T)      727 (T)      727 (T)      ---         |---          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.141N     P=0.405      P=0.534      P=0.238N    |(e)          (e)          (e)          (e)          |
|POLY 3             |     P=0.146N     P=0.347      P=0.508      P=0.244N    |(e)          (e)          (e)          (e)          |
|POLY 1.5           |     P=0.142N     P=0.342      P=0.505      P=0.241N    |(e)          (e)          (e)          (e)          |
|POLY 6             |     P=0.150N     P=0.355      P=0.511      P=0.246N    |(e)          (e)          (e)          (e)          |
|LOGISTIC REGRESSION|     P=0.141N     P=0.405      P=0.534      (e)         |(e)          (e)          (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.137N     P=0.339      P=0.500      P=0.247N    |(e)          (e)          (e)          (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Intestine Small: Jejunum                                                                                                         |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     5/50 (10%)   1/50 (2%)    1/50 (2%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     10.6%        2.1%         2.1%         0.0%        |0.0%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     4/39 (10%)   1/45 (2%)    1/42 (2%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |     643          727 (T)      727 (T)      ---         |---          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.016N*    P=0.081N     P=0.092N     P=0.036N*   |(e)          (e)          (e)          (e)          |
|POLY 3             |     P=0.016N*    P=0.098N     P=0.099N     P=0.034N*   |(e)          (e)          (e)          (e)          |
|POLY 1.5           |     P=0.015N*    P=0.100N     P=0.100N     P=0.033N*   |(e)          (e)          (e)          (e)          |
|POLY 6             |     P=0.016N*    P=0.095N     P=0.098N     P=0.035N*   |(e)          (e)          (e)          (e)          |
|LOGISTIC REGRESSION|     P=0.016N*    P=0.102N     P=0.101N     P=0.035N*   |(e)          (e)          (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.016N*    P=0.102N     P=0.102N     P=0.028N*   |(e)          (e)          (e)          (e)          |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 4
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Intestine Small: Site Unspecified                                                                                                |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     5/50 (10%)   2/50 (4%)    1/50 (2%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     10.6%        4.2%         2.1%         0.0%        |0.0%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     4/39 (10%)   2/45 (4%)    1/42 (2%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |     643          727 (T)      727 (T)      ---         |---          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.014N*    P=0.173N     P=0.092N     P=0.036N*   |(e)          (e)          (e)          (e)          |
|POLY 3             |     P=0.014N*    P=0.211N     P=0.099N     P=0.034N*   |(e)          (e)          (e)          (e)          |
|POLY 1.5           |     P=0.014N*    P=0.214N     P=0.100N     P=0.033N*   |(e)          (e)          (e)          (e)          |
|POLY 6             |     P=0.015N*    P=0.206N     P=0.098N     P=0.035N*   |(e)          (e)          (e)          (e)          |
|LOGISTIC REGRESSION|     P=0.015N*    P=0.211N     P=0.101N     P=0.035N*   |(e)          (e)          (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.014N*    P=0.218N     P=0.102N     P=0.028N*   |(e)          (e)          (e)          (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Intestine Small: Site Unspecified                                                                                                |
|     Polyp Adenomatous                                                                                                           |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    4/50 (8%)    3/50 (6%)    1/50 (2%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     4.3%         8.4%         6.3%         2.2%        |0.0%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     2/39 (5%)    4/45 (9%)    3/42 (7%)    1/39 (3%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |     727 (T)      727 (T)      727 (T)      727 (T)     |---          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.305N     P=0.405      P=0.534      P=0.500N    |(e)          (e)          (e)          (e)          |
|POLY 3             |     P=0.307N     P=0.347      P=0.508      P=0.510N    |(e)          (e)          (e)          (e)          |
|POLY 1.5           |     P=0.301N     P=0.342      P=0.505      P=0.506N    |(e)          (e)          (e)          (e)          |
|POLY 6             |     P=0.313N     P=0.355      P=0.511      P=0.514N    |(e)          (e)          (e)          (e)          |
|LOGISTIC REGRESSION|     P=0.305N     P=0.405      P=0.534      P=0.500N    |(e)          (e)          (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.292N     P=0.339      P=0.500      P=0.500N    |(e)          (e)          (e)          (e)          |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 5
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Islets, Pancreatic                                                                                                               |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     3/50 (6%)    2/50 (4%)    2/50 (4%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    3/50 (6%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     6.4%         4.2%         4.2%         0.0%        |0.0%         0.0%         6.4%         0.0%         |
|TERMINAL (d)       |     1/39 (3%)    2/45 (4%)    2/42 (5%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    2/37 (5%)    0/41 (0%)    |
|FIRST INCIDENCE    |     652          727 (T)      727 (T)      ---         |---          ---          716          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.092N     P=0.457N     P=0.480N     P=0.131N    |P=0.555      (e)          P=0.114      (e)          |
|POLY 3             |     P=0.093N     P=0.495N     P=0.497N     P=0.126N    |P=0.550      (e)          P=0.123      (e)          |
|POLY 1.5           |     P=0.090N     P=0.497N     P=0.497N     P=0.123N    |P=0.543      (e)          P=0.121      (e)          |
|POLY 6             |     P=0.096N     P=0.490N     P=0.497N     P=0.129N    |P=0.562      (e)          P=0.125      (e)          |
|LOGISTIC REGRESSION|     P=0.086N     P=0.505N     P=0.511N     P=0.111N    |P=0.556      (e)          P=0.125      (e)          |
|COCH-ARM / FISHERS |     P=0.086N     P=0.500N     P=0.500N     P=0.121N    |P=0.539      (e)          P=0.121      (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Islets, Pancreatic                                                                                                               |
|     Carcinoma or Adenoma                                                                                                        |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     3/50 (6%)    3/50 (6%)    2/50 (4%)    0/50 (0%)   |0/50 (0%)    1/50 (2%)    3/50 (6%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     6.4%         6.3%         4.2%         0.0%        |0.0%         2.2%         6.4%         0.0%         |
|TERMINAL (d)       |     1/39 (3%)    3/45 (7%)    2/42 (5%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    2/37 (5%)    0/41 (0%)    |
|FIRST INCIDENCE    |     652          727 (T)      727 (T)      ---         |---          664          716          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.077N     P=0.613N     P=0.480N     P=0.131N    |P=0.609N     P=0.500      P=0.114      (e)          |
|POLY 3             |     P=0.078N     P=0.657N     P=0.497N     P=0.126N    |P=0.627N     P=0.501      P=0.123      (e)          |
|POLY 1.5           |     P=0.075N     P=0.659N     P=0.497N     P=0.123N    |P=0.631N     P=0.501      P=0.121      (e)          |
|POLY 6             |     P=0.081N     P=0.652N     P=0.497N     P=0.129N    |P=0.618N     P=0.498      P=0.125      (e)          |
|LOGISTIC REGRESSION|     P=0.073N     P=0.661      P=0.511N     P=0.111N    |P=0.632N     P=0.483      P=0.125      (e)          |
|COCH-ARM / FISHERS |     P=0.072N     P=0.661N     P=0.500N     P=0.121N    |P=0.634      P=0.500      P=0.121      (e)          |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 6
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    2/50 (4%)    1/50 (2%)    2/50 (4%)   |0/50 (0%)    0/50 (0%)    1/50 (2%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     4.3%         4.2%         2.1%         4.3%        |0.0%         0.0%         2.1%         0.0%         |
|TERMINAL (d)       |     1/39 (3%)    2/45 (4%)    0/42 (0%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    1/37 (3%)    0/41 (0%)    |
|FIRST INCIDENCE    |     705          727 (T)      664          549         |---          ---          728 (T)      ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.595N     P=0.646N     P=0.481N     P=0.683     |P=0.698      (e)          P=0.484      (e)          |
|POLY 3             |     P=0.582N     P=0.687N     P=0.493N     P=0.688     |P=0.700      (e)          P=0.504      (e)          |
|POLY 1.5           |     P=0.580N     P=0.690N     P=0.496N     P=0.690     |P=0.696      (e)          P=0.503      (e)          |
|POLY 6             |     P=0.583N     P=0.681N     P=0.490N     P=0.687     |P=0.708      (e)          P=0.506      (e)          |
|LOGISTIC REGRESSION|     P=0.538N     P=0.681N     P=0.516N     P=0.657N    |(e)          (e)          P=0.484      (e)          |
|COCH-ARM / FISHERS |     P=0.577N     P=0.691N     P=0.500N     P=0.691N    |P=0.694      (e)          P=0.500      (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatoblastoma                                                                                                              |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     5/50 (10%)   1/50 (2%)    2/50 (4%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     10.6%        2.1%         4.2%         0.0%        |0.0%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     3/39 (8%)    1/45 (2%)    2/42 (5%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |     617          727 (T)      727 (T)      ---         |---          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.027N*    P=0.085N     P=0.199N     P=0.039N*   |(e)          (e)          (e)          (e)          |
|POLY 3             |     P=0.027N*    P=0.099N     P=0.214N     P=0.034N*   |(e)          (e)          (e)          (e)          |
|POLY 1.5           |     P=0.026N*    P=0.101N     P=0.215N     P=0.033N*   |(e)          (e)          (e)          (e)          |
|POLY 6             |     P=0.028N*    P=0.097N     P=0.214N     P=0.036N*   |(e)          (e)          (e)          (e)          |
|LOGISTIC REGRESSION|     P=0.025N*    P=0.105N     P=0.220N     P=0.032N*   |(e)          (e)          (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.025N*    P=0.102N     P=0.218N     P=0.028N*   |(e)          (e)          (e)          (e)          |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 7
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Adenoma                                                                                                      |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     19/50 (38%)  17/50 (34%)  13/50 (26%)  18/50 (36%) |9/50 (18%)   7/50 (14%)   3/50 (6%)    6/50 (12%)   |
|POLY-3 ADJUSTED (b)|     40.1%        35.4%        27.3%        38.5%       |19.5%        15.2%        6.4%         12.9%        |
|TERMINAL (d)       |     16/39 (41%)  16/45 (36%)  13/42 (31%)  14/39 (36%) |8/40 (20%)   5/34 (15%)   3/37 (8%)    6/41 (15%)   |
|FIRST INCIDENCE    |     643          637          727 (T)      472         |586          667          728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.514N     P=0.247N     P=0.095N     P=0.513N    |P=0.171N     P=0.506N     P=0.079N     P=0.271N     |
|POLY 3             |     P=0.473N     P=0.395N     P=0.134N     P=0.521N    |P=0.197N     P=0.394N     P=0.057N     P=0.283N     |
|POLY 1.5           |     P=0.463N     P=0.406N     P=0.136N     P=0.513N    |P=0.201N     P=0.392N     P=0.058N     P=0.287N     |
|POLY 6             |     P=0.486N     P=0.377N     P=0.135N     P=0.528N    |P=0.190N     P=0.406N     P=0.055N     P=0.276N     |
|LOGISTIC REGRESSION|     P=0.504N     P=0.374N     P=0.118N     P=0.534N    |P=0.184N     P=0.394N     P=0.056N     P=0.270N     |
|COCH-ARM / FISHERS |     P=0.450N     P=0.418N     P=0.142N     P=0.500N    |P=0.203N     P=0.393N     P=0.061N     P=0.288N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Carcinoma                                                                                                    |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     9/50 (18%)   10/50 (20%)  6/50 (12%)   9/50 (18%)  |2/50 (4%)    2/50 (4%)    4/50 (8%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|     19.1%        20.6%        12.5%        19.3%       |4.4%         4.4%         8.5%         2.2%         |
|TERMINAL (d)       |     8/39 (21%)   8/45 (18%)   5/42 (12%)   5/39 (13%)  |2/40 (5%)    1/34 (3%)    3/37 (8%)    1/41 (2%)    |
|FIRST INCIDENCE    |     617          601          596          583         |728 (T)      673          691          728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.519N     P=0.585N     P=0.245N     P=0.588     |P=0.399N     P=0.645      P=0.312      P=0.491N     |
|POLY 3             |     P=0.490N     P=0.527      P=0.275N     P=0.591     |P=0.422N     P=0.693N     P=0.349      P=0.494N     |
|POLY 1.5           |     P=0.485N     P=0.514      P=0.280N     P=0.594     |P=0.428N     P=0.692N     P=0.344      P=0.498N     |
|POLY 6             |     P=0.493N     P=0.548      P=0.269N     P=0.594     |P=0.411N     P=0.690      P=0.354      P=0.489N     |
|LOGISTIC REGRESSION|     P=0.458N     P=0.499      P=0.287N     P=0.602N    |P=0.417N     P=0.692      P=0.351      P=0.491N     |
|COCH-ARM / FISHERS |     P=0.475N     P=0.500      P=0.288N     P=0.602N    |P=0.431N     P=0.691N     P=0.339      P=0.500N     |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 8
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Carcinoma or Hepatoblastoma                                                                                  |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     12/50 (24%)  11/50 (22%)  7/50 (14%)   9/50 (18%)  |2/50 (4%)    2/50 (4%)    4/50 (8%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|     25.4%        22.7%        14.6%        19.3%       |4.4%         4.4%         8.5%         2.2%         |
|TERMINAL (d)       |     10/39 (26%)  9/45 (20%)   6/42 (14%)   5/39 (13%)  |2/40 (5%)    1/34 (3%)    3/37 (8%)    1/41 (2%)    |
|FIRST INCIDENCE    |     617          601          596          583         |728 (T)      673          691          728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.267N     P=0.374N     P=0.124N     P=0.332N    |P=0.399N     P=0.645      P=0.312      P=0.491N     |
|POLY 3             |     P=0.239N     P=0.472N     P=0.143N     P=0.325N    |P=0.422N     P=0.693N     P=0.349      P=0.494N     |
|POLY 1.5           |     P=0.235N     P=0.486N     P=0.147N     P=0.321N    |P=0.428N     P=0.692N     P=0.344      P=0.498N     |
|POLY 6             |     P=0.243N     P=0.451N     P=0.139N     P=0.324N    |P=0.411N     P=0.690      P=0.354      P=0.489N     |
|LOGISTIC REGRESSION|     P=0.219N     P=0.497N     P=0.150N     P=0.316N    |P=0.417N     P=0.692      P=0.351      P=0.491N     |
|COCH-ARM / FISHERS |     P=0.225N     P=0.500N     P=0.154N     P=0.312N    |P=0.431N     P=0.691N     P=0.339      P=0.500N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Carcinoma or Hepatocellular Adenoma                                                                          |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     24/50 (48%)  24/50 (48%)  16/50 (32%)  25/50 (50%) |10/50 (20%)  8/50 (16%)   7/50 (14%)   7/50 (14%)   |
|POLY-3 ADJUSTED (b)|     50.2%        49.2%        33.3%        52.4%       |21.6%        17.3%        14.9%        15.1%        |
|TERMINAL (d)       |     20/39 (51%)  21/45 (47%)  15/42 (36%)  18/39 (46%) |9/40 (23%)   6/34 (18%)   6/37 (16%)   7/41 (17%)   |
|FIRST INCIDENCE    |     617          601          596          472         |586          667          691          728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.447      P=0.354N     P=0.048N*    P=0.482     |P=0.212N     P=0.523N     P=0.349N     P=0.278N     |
|POLY 3             |     P=0.516      P=0.539N     P=0.068N     P=0.499     |P=0.250N     P=0.399N     P=0.285N     P=0.292N     |
|POLY 1.5           |     P=0.521      P=0.558N     P=0.070N     P=0.498     |P=0.256N     P=0.396N     P=0.290N     P=0.296N     |
|POLY 6             |     P=0.513      P=0.508N     P=0.067N     P=0.508     |P=0.239N     P=0.412N     P=0.280N     P=0.284N     |
|LOGISTIC REGRESSION|     P=0.506      P=0.560N     P=0.066N     P=0.479     |P=0.229N     P=0.402N     P=0.277N     P=0.276N     |
|COCH-ARM / FISHERS |     P=0.529      P=0.579N     P=0.076N     P=0.500     |P=0.257N     P=0.398N     P=0.298N     P=0.298N     |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 9
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Carcinoma, Hepatocellular Adenoma,                                                                           |
|     or Hepatoblastoma                                                                                                           |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     26/50 (52%)  25/50 (50%)  17/50 (34%)  25/50 (50%) |10/50 (20%)  8/50 (16%)   7/50 (14%)   7/50 (14%)   |
|POLY-3 ADJUSTED (b)|     54.3%        51.2%        35.4%        52.4%       |21.6%        17.3%        14.9%        15.1%        |
|TERMINAL (d)       |     21/39 (54%)  22/45 (49%)  16/42 (38%)  18/39 (46%) |9/40 (23%)   6/34 (18%)   6/37 (16%)   7/41 (17%)   |
|FIRST INCIDENCE    |     617          601          596          472         |586          667          691          728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.484N     P=0.279N     P=0.033N*    P=0.520N    |P=0.212N     P=0.523N     P=0.349N     P=0.278N     |
|POLY 3             |     P=0.410N     P=0.460N     P=0.046N*    P=0.506N    |P=0.250N     P=0.399N     P=0.285N     P=0.292N     |
|POLY 1.5           |     P=0.404N     P=0.479N     P=0.048N*    P=0.505N    |P=0.256N     P=0.396N     P=0.290N     P=0.296N     |
|POLY 6             |     P=0.415N     P=0.430N     P=0.046N*    P=0.501N    |P=0.239N     P=0.412N     P=0.280N     P=0.284N     |
|LOGISTIC REGRESSION|     P=0.422N     P=0.478N     P=0.044N*    P=0.524N    |P=0.229N     P=0.402N     P=0.277N     P=0.276N     |
|COCH-ARM / FISHERS |     P=0.396N     P=0.500N     P=0.053N     P=0.500N    |P=0.257N     P=0.398N     P=0.298N     P=0.298N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Lung                                                                                                                             |
|     Alveolar/Bronchiolar Adenoma                                                                                                |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     10/50 (20%)  5/50 (10%)   9/50 (18%)   10/50 (20%) |1/50 (2%)    4/50 (8%)    3/50 (6%)    5/50 (10%)   |
|POLY-3 ADJUSTED (b)|     21.2%        10.4%        18.9%        22.0%       |2.2%         8.7%         6.4%         10.8%        |
|TERMINAL (d)       |     9/39 (23%)   4/45 (9%)    8/42 (19%)   10/39 (26%) |1/40 (3%)    2/34 (6%)    3/37 (8%)    5/41 (12%)   |
|FIRST INCIDENCE    |     617          644          707          727 (T)     |728 (T)      659          728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.333      P=0.087N     P=0.433N     P=0.596     |P=0.142      P=0.154      P=0.278      P=0.109      |
|POLY 3             |     P=0.335      P=0.121N     P=0.490N     P=0.562     |P=0.118      P=0.181      P=0.313      P=0.105      |
|POLY 1.5           |     P=0.352      P=0.126N     P=0.494N     P=0.576     |P=0.115      P=0.181      P=0.310      P=0.103      |
|POLY 6             |     P=0.315      P=0.114N     P=0.487N     P=0.546     |P=0.123      P=0.178      P=0.316      P=0.108      |
|LOGISTIC REGRESSION|     P=0.327      P=0.127N     P=0.477N     P=0.558     |P=0.122      P=0.179      P=0.278      P=0.109      |
|COCH-ARM / FISHERS |     P=0.375      P=0.131N     P=0.500N     P=0.598N    |P=0.113      P=0.181      P=0.309      P=0.102      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 10
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Lung                                                                                                                             |
|     Alveolar/Bronchiolar Carcinoma                                                                                              |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     4/50 (8%)    1/50 (2%)    3/50 (6%)    7/50 (14%)  |0/50 (0%)    3/50 (6%)    2/50 (4%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|     8.4%         2.1%         6.3%         15.1%       |0.0%         6.6%         4.3%         2.2%         |
|TERMINAL (d)       |     3/39 (8%)    1/45 (2%)    3/42 (7%)    5/39 (13%)  |0/40 (0%)    3/34 (9%)    2/37 (5%)    1/41 (2%)    |
|FIRST INCIDENCE    |     526          727 (T)      727 (T)      502         |---          728 (T)      728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.070      P=0.149N     P=0.464N     P=0.262     |P=0.580      P=0.094      P=0.221      P=0.505      |
|POLY 3             |     P=0.074      P=0.177N     P=0.498N     P=0.249     |P=0.566      P=0.118      P=0.242      P=0.503      |
|POLY 1.5           |     P=0.076      P=0.178N     P=0.499N     P=0.254     |P=0.560      P=0.119      P=0.240      P=0.501      |
|POLY 6             |     P=0.071      P=0.173N     P=0.497N     P=0.246     |P=0.575      P=0.115      P=0.244      P=0.506      |
|LOGISTIC REGRESSION|     P=0.098      P=0.185N     P=0.525N     P=0.304     |(e)          P=0.094      P=0.221      P=0.505      |
|COCH-ARM / FISHERS |     P=0.080      P=0.181N     P=0.500N     P=0.262     |P=0.556      P=0.121      P=0.247      P=0.500      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Lung                                                                                                                             |
|     Alveolar/Bronchiolar Carcinoma or Alveolar/Bronchiolar                                                                      |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     13/50 (26%)  6/50 (12%)   12/50 (24%)  17/50 (34%) |1/50 (2%)    6/50 (12%)   5/50 (10%)   6/50 (12%)   |
|POLY-3 ADJUSTED (b)|     27.2%        12.5%        25.2%        36.6%       |2.2%         13.0%        10.7%        12.9%        |
|TERMINAL (d)       |     11/39 (28%)  5/45 (11%)   11/42 (26%)  15/39 (39%) |1/40 (3%)    4/34 (12%)   5/37 (14%)   6/41 (15%)   |
|FIRST INCIDENCE    |     526          644          707          502         |728 (T)      659          728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.056      P=0.037N*    P=0.422N     P=0.253     |P=0.136      P=0.044 *    P=0.086      P=0.062      |
|POLY 3             |     P=0.057      P=0.059N     P=0.503N     P=0.223     |P=0.110      P=0.057      P=0.106      P=0.059      |
|POLY 1.5           |     P=0.063      P=0.061N     P=0.501N     P=0.236     |P=0.107      P=0.057      P=0.105      P=0.057      |
|POLY 6             |     P=0.051      P=0.055N     P=0.506N     P=0.211     |P=0.116      P=0.055      P=0.108      P=0.061      |
|LOGISTIC REGRESSION|     P=0.066      P=0.065N     P=0.490N     P=0.248     |P=0.120      P=0.058      P=0.086      P=0.062      |
|COCH-ARM / FISHERS |     P=0.073      P=0.062N     P=0.500N     P=0.257     |P=0.105      P=0.056      P=0.102      P=0.056      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 11
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Ovary                                                                                                                            |
|     Cystadenoma                                                                                                                 |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |                                                        |0/47 (0%)    2/49 (4%)    1/50 (2%)    3/49 (6%)    |
|POLY-3 ADJUSTED (b)|                                                        |0.0%         4.5%         2.1%         6.6%         |
|TERMINAL (d)       |                                                        |0/37 (0%)    2/33 (6%)    1/37 (3%)    3/40 (8%)    |
|FIRST INCIDENCE    |                                                        |---          728 (T)      728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |                                                        |P=0.130      P=0.213      P=0.500      P=0.135      |
|POLY 3             |                                                        |P=0.113      P=0.247      P=0.518      P=0.130      |
|POLY 1.5           |                                                        |P=0.111      P=0.248      P=0.516      P=0.128      |
|POLY 6             |                                                        |P=0.117      P=0.243      P=0.520      P=0.133      |
|LOGISTIC REGRESSION|                                                        |(e)          P=0.213      P=0.500      P=0.135      |
|COCH-ARM / FISHERS |                                                        |P=0.108      P=0.258      P=0.515      P=0.129      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Ovary                                                                                                                            |
|     Hemangioma                                                                                                                  |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |                                                        |0/47 (0%)    2/49 (4%)    1/50 (2%)    1/49 (2%)    |
|POLY-3 ADJUSTED (b)|                                                        |0.0%         4.5%         2.1%         2.2%         |
|TERMINAL (d)       |                                                        |0/37 (0%)    2/33 (6%)    1/37 (3%)    1/40 (3%)    |
|FIRST INCIDENCE    |                                                        |---          728 (T)      728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |                                                        |P=0.535      P=0.213      P=0.500      P=0.516      |
|POLY 3             |                                                        |P=0.520      P=0.247      P=0.518      P=0.512      |
|POLY 1.5           |                                                        |P=0.515      P=0.248      P=0.516      P=0.510      |
|POLY 6             |                                                        |P=0.528      P=0.243      P=0.520      P=0.516      |
|LOGISTIC REGRESSION|                                                        |(e)          P=0.213      P=0.500      P=0.516      |
|COCH-ARM / FISHERS |                                                        |P=0.511      P=0.258      P=0.515      P=0.510      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 12
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Pituitary Gland: Pars Distalis or Unspecified Site                                                                               |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/49 (0%)    0/49 (0%)    0/47 (0%)    0/47 (0%)   |1/48 (2%)    3/47 (6%)    0/43 (0%)    1/48 (2%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |2.3%         6.9%         0.0%         2.2%         |
|TERMINAL (d)       |     0/38 (0%)    0/44 (0%)    0/40 (0%)    0/37 (0%)   |1/38 (3%)    2/32 (6%)    0/33 (0%)    1/40 (3%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |728 (T)      643          ---          728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.384N     P=0.273      P=0.528N     P=0.750N     |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.401N     P=0.305      P=0.515N     P=0.754N     |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.406N     P=0.303      P=0.518N     P=0.757N     |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.396N     P=0.301      P=0.513N     P=0.749N     |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.408N     P=0.299      (e)          P=0.750N     |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.412N     P=0.301      P=0.527N     P=0.753N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Skin                                                                                                                             |
|     Fibroma, Fibrosarcoma, Sarcoma, Myxoma, Myxosarcoma,                                                                        |
|     or Fibrous Histiocytoma                                                                                                     |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |1/50 (2%)    5/50 (10%)   1/50 (2%)    3/50 (6%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |2.2%         10.7%        2.1%         6.4%         |
|TERMINAL (d)       |     0/39 (0%)    0/45 (0%)    0/42 (0%)    0/39 (0%)   |0/40 (0%)    1/34 (3%)    0/37 (0%)    2/41 (5%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |586          651          477          705          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.491      P=0.103      P=0.753N     P=0.317      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.462      P=0.103      P=0.755N     P=0.308      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.459      P=0.103      P=0.757N     P=0.306      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.468      P=0.101      P=0.753N     P=0.312      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.474      P=0.081      P=0.741      P=0.303      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.456      P=0.102      P=0.753N     P=0.309      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 13
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Skin                                                                                                                             |
|     Fibrosarcoma                                                                                                                |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |0/50 (0%)    5/50 (10%)   1/50 (2%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |0.0%         10.7%        2.1%         4.3%         |
|TERMINAL (d)       |     0/39 (0%)    0/45 (0%)    0/42 (0%)    0/39 (0%)   |0/40 (0%)    1/34 (3%)    0/37 (0%)    1/41 (2%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |---          651          477          705          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.534      P=0.032 *    P=0.504      P=0.248      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.514      P=0.032 *    P=0.507      P=0.241      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.507      P=0.032 *    P=0.505      P=0.239      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.524      P=0.032 *    P=0.510      P=0.245      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.517      P=0.029 *    P=0.405      P=0.241      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.500      P=0.028 *    P=0.500      P=0.247      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Skin                                                                                                                             |
|     Fibrosarcoma, Sarcoma, Myxosarcoma, or Fibrous Histiocytoma                                                                 |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |1/50 (2%)    5/50 (10%)   1/50 (2%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |2.2%         10.7%        2.1%         4.3%         |
|TERMINAL (d)       |     0/39 (0%)    0/45 (0%)    0/42 (0%)    0/39 (0%)   |0/40 (0%)    1/34 (3%)    0/37 (0%)    1/41 (2%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |586          651          477          705          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.491N     P=0.103      P=0.753N     P=0.508      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.517N     P=0.103      P=0.755N     P=0.503      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.520N     P=0.103      P=0.757N     P=0.501      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.512N     P=0.101      P=0.753N     P=0.506      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.498N     P=0.081      P=0.741      P=0.501      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.523N     P=0.102      P=0.753N     P=0.500      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 14
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Skin                                                                                                                             |
|     Schwannoma Malignant                                                                                                        |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |0.0%         0.0%         0.0%         4.2%         |
|TERMINAL (d)       |     0/39 (0%)    0/45 (0%)    0/42 (0%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    1/41 (2%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |---          ---          ---          520          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.051      (e)          (e)          P=0.240      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.047 *    (e)          (e)          P=0.244      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.046 *    (e)          (e)          P=0.241      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.048 *    (e)          (e)          P=0.249      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.060      (e)          (e)          P=0.249      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.046 *    (e)          (e)          P=0.247      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Spleen                                                                                                                           |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     3/50 (6%)    0/50 (0%)    2/50 (4%)    0/50 (0%)   |0/49 (0%)    1/50 (2%)    2/50 (4%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     6.4%         0.0%         4.2%         0.0%        |0.0%         2.2%         4.3%         0.0%         |
|TERMINAL (d)       |     2/39 (5%)    0/45 (0%)    1/42 (2%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    2/37 (5%)    0/41 (0%)    |
|FIRST INCIDENCE    |     661          ---          707          ---         |---          605          728 (T)      ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.131N     P=0.105N     P=0.472N     P=0.126N    |P=0.602N     P=0.517      P=0.221      (e)          |
|POLY 3             |     P=0.131N     P=0.116N     P=0.494N     P=0.125N    |P=0.610N     P=0.503      P=0.244      (e)          |
|POLY 1.5           |     P=0.128N     P=0.118N     P=0.496N     P=0.123N    |P=0.612N     P=0.504      P=0.243      (e)          |
|POLY 6             |     P=0.135N     P=0.114N     P=0.492N     P=0.128N    |P=0.605N     P=0.500      P=0.245      (e)          |
|LOGISTIC REGRESSION|     P=0.125N     P=0.122N     P=0.501N     P=0.121N    |P=0.607N     P=0.459      P=0.221      (e)          |
|COCH-ARM / FISHERS |     P=0.125N     P=0.121N     P=0.500N     P=0.121N    |P=0.612N     P=0.505      P=0.253      (e)          |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 15
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Stomach, Forestomach                                                                                                             |
|     Squamous Cell Carcinoma                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |0.0%         0.0%         0.0%         4.3%         |
|TERMINAL (d)       |     0/39 (0%)    0/45 (0%)    0/42 (0%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    2/41 (5%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |---          ---          ---          728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.055      (e)          (e)          P=0.244      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.046 *    (e)          (e)          P=0.241      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.046 *    (e)          (e)          P=0.239      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.047 *    (e)          (e)          P=0.244      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |(e)          (e)          (e)          P=0.244      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.046 *    (e)          (e)          P=0.247      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Stomach, Forestomach                                                                                                             |
|     Squamous Cell Carcinoma or Papilloma Squamous                                                                               |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    1/50 (2%)    0/50 (0%)    1/50 (2%)   |1/50 (2%)    0/50 (0%)    1/50 (2%)    5/50 (10%)   |
|POLY-3 ADJUSTED (b)|     2.1%         2.1%         0.0%         2.2%        |2.2%         0.0%         2.1%         10.7%        |
|TERMINAL (d)       |     1/39 (3%)    1/45 (2%)    0/42 (0%)    1/39 (3%)   |1/40 (3%)    0/34 (0%)    1/37 (3%)    4/41 (10%)   |
|FIRST INCIDENCE    |     727 (T)      727 (T)      ---          727 (T)     |728 (T)      ---          728 (T)      708          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.629N     P=0.730N     P=0.485N     P=0.762     |P=0.016 *    P=0.532N     P=0.744      P=0.111      |
|POLY 3             |     P=0.616N     P=0.756N     P=0.497N     P=0.754     |P=0.011 *    P=0.500N     P=0.756N     P=0.106      |
|POLY 1.5           |     P=0.616N     P=0.758N     P=0.498N     P=0.756     |P=0.011 *    P=0.500N     P=0.758N     P=0.104      |
|POLY 6             |     P=0.617N     P=0.752N     P=0.495N     P=0.752     |P=0.012 *    P=0.504N     P=0.754N     P=0.109      |
|LOGISTIC REGRESSION|     P=0.629N     P=0.730N     (e)          P=0.762     |P=0.014 *    (e)          P=0.744      P=0.112      |
|COCH-ARM / FISHERS |     P=0.616N     P=0.753N     P=0.500N     P=0.753N    |P=0.011 *    P=0.500N     P=0.753N     P=0.102      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 16
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Stomach, Forestomach                                                                                                             |
|     Squamous Cell Papilloma                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    1/50 (2%)    0/50 (0%)    1/50 (2%)   |1/50 (2%)    0/50 (0%)    1/50 (2%)    3/50 (6%)    |
|POLY-3 ADJUSTED (b)|     2.1%         2.1%         0.0%         2.2%        |2.2%         0.0%         2.1%         6.4%         |
|TERMINAL (d)       |     1/39 (3%)    1/45 (2%)    0/42 (0%)    1/39 (3%)   |1/40 (3%)    0/34 (0%)    1/37 (3%)    2/41 (5%)    |
|FIRST INCIDENCE    |     727 (T)      727 (T)      ---          727 (T)     |728 (T)      ---          728 (T)      708          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.629N     P=0.730N     P=0.485N     P=0.762     |P=0.114      P=0.532N     P=0.744      P=0.316      |
|POLY 3             |     P=0.616N     P=0.756N     P=0.497N     P=0.754     |P=0.099      P=0.500N     P=0.756N     P=0.312      |
|POLY 1.5           |     P=0.616N     P=0.758N     P=0.498N     P=0.756     |P=0.097      P=0.500N     P=0.758N     P=0.308      |
|POLY 6             |     P=0.617N     P=0.752N     P=0.495N     P=0.752     |P=0.103      P=0.504N     P=0.754N     P=0.318      |
|LOGISTIC REGRESSION|     P=0.629N     P=0.730N     (e)          P=0.762     |P=0.108      (e)          P=0.744      P=0.317      |
|COCH-ARM / FISHERS |     P=0.616N     P=0.753N     P=0.500N     P=0.753N    |P=0.097      P=0.500N     P=0.753N     P=0.309      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Testes                                                                                                                           |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    2/50 (4%)    0/50 (0%)    0/50 (0%)   |                                                    |
|POLY-3 ADJUSTED (b)|     0.0%         4.2%         0.0%         0.0%        |                                                    |
|TERMINAL (d)       |     0/39 (0%)    2/45 (4%)    0/42 (0%)    0/39 (0%)   |                                                    |
|FIRST INCIDENCE    |     ---          727 (T)      ---          ---         |                                                    |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.412N     P=0.270      (e)          (e)         |                                                    |
|POLY 3             |     P=0.405N     P=0.242      (e)          (e)         |                                                    |
|POLY 1.5           |     P=0.405N     P=0.240      (e)          (e)         |                                                    |
|POLY 6             |     P=0.404N     P=0.246      (e)          (e)         |                                                    |
|LOGISTIC REGRESSION|     (e)          P=0.270      (e)          (e)         |                                                    |
|COCH-ARM / FISHERS |     P=0.405N     P=0.247      (e)          (e)         |                                                    |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 17
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Tooth                                                                                                                            |
|     Odontoma                                                                                                                    |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    2/50 (4%)    1/50 (2%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     0.0%         4.2%         2.1%         0.0%        |0.0%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     0/39 (0%)    2/45 (4%)    1/42 (2%)    0/39 (0%)   |0/40 (0%)    0/34 (0%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |     ---          727 (T)      727 (T)      ---         |---          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.471N     P=0.270      P=0.515      (e)         |(e)          (e)          (e)          (e)          |
|POLY 3             |     P=0.469N     P=0.242      P=0.503      (e)         |(e)          (e)          (e)          (e)          |
|POLY 1.5           |     P=0.466N     P=0.240      P=0.502      (e)         |(e)          (e)          (e)          (e)          |
|POLY 6             |     P=0.471N     P=0.246      P=0.505      (e)         |(e)          (e)          (e)          (e)          |
|LOGISTIC REGRESSION|     (e)          P=0.270      P=0.515      (e)         |(e)          (e)          (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.461N     P=0.247      P=0.500      (e)         |(e)          (e)          (e)          (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|Uterus                                                                                                                           |
|     Polyp Stromal                                                                                                               |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |                                                        |0/50 (0%)    3/50 (6%)    0/50 (0%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|                                                        |0.0%         6.5%         0.0%         2.1%         |
|TERMINAL (d)       |                                                        |0/40 (0%)    1/34 (3%)    0/37 (0%)    0/41 (0%)    |
|FIRST INCIDENCE    |                                                        |---          664          ---          659          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |                                                        |P=0.607N     P=0.107      (e)          P=0.518      |
|POLY 3             |                                                        |P=0.627N     P=0.120      (e)          P=0.504      |
|POLY 1.5           |                                                        |P=0.631N     P=0.120      (e)          P=0.502      |
|POLY 6             |                                                        |P=0.624N     P=0.117      (e)          P=0.508      |
|LOGISTIC REGRESSION|                                                        |P=0.633N     P=0.120      (e)          P=0.504      |
|COCH-ARM / FISHERS |                                                        |P=0.634      P=0.121      (e)          P=0.500      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 18
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Hemangioma                                                                                                                  |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |0/50 (0%)    2/50 (4%)    1/50 (2%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |0.0%         4.4%         2.1%         2.2%         |
|TERMINAL (d)       |     0/39 (0%)    0/45 (0%)    0/42 (0%)    0/39 (0%)   |0/40 (0%)    2/34 (6%)    1/37 (3%)    1/41 (2%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |---          728 (T)      728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.521      P=0.203      P=0.484      P=0.505      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.508      P=0.237      P=0.504      P=0.503      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.503      P=0.238      P=0.503      P=0.501      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.515      P=0.233      P=0.506      P=0.506      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |(e)          P=0.203      P=0.484      P=0.505      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.500      P=0.247      P=0.500      P=0.500      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     7/50 (14%)   2/50 (4%)    3/50 (6%)    2/50 (4%)   |1/50 (2%)    1/50 (2%)    3/50 (6%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     14.9%        4.2%         6.3%         4.3%        |2.2%         2.2%         6.4%         0.0%         |
|TERMINAL (d)       |     5/39 (13%)   2/45 (4%)    1/42 (2%)    0/39 (0%)   |1/40 (3%)    0/34 (0%)    3/37 (8%)    0/41 (0%)    |
|FIRST INCIDENCE    |     661          727 (T)      664          549         |728 (T)      605          728 (T)      ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.091N     P=0.059N     P=0.142N     P=0.092N    |P=0.393N     P=0.752      P=0.278      P=0.495N     |
|POLY 3             |     P=0.083N     P=0.076N     P=0.151N     P=0.084N    |P=0.402N     P=0.759N     P=0.313      P=0.497N     |
|POLY 1.5           |     P=0.082N     P=0.078N     P=0.154N     P=0.083N    |P=0.407N     P=0.759N     P=0.310      P=0.499N     |
|POLY 6             |     P=0.085N     P=0.073N     P=0.148N     P=0.086N    |P=0.393N     P=0.760      P=0.316      P=0.494N     |
|LOGISTIC REGRESSION|     P=0.073N     P=0.076N     P=0.159N     P=0.073N    |P=0.410N     P=0.748      P=0.278      (e)          |
|COCH-ARM / FISHERS |     P=0.080N     P=0.080N     P=0.159N     P=0.080N    |P=0.409N     P=0.753N     P=0.309      P=0.500N     |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 19
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Hemangiosarcoma or Hemangioma                                                                                               |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     7/50 (14%)   2/50 (4%)    3/50 (6%)    2/50 (4%)   |1/50 (2%)    3/50 (6%)    4/50 (8%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|     14.9%        4.2%         6.3%         4.3%        |2.2%         6.5%         8.6%         2.2%         |
|TERMINAL (d)       |     5/39 (13%)   2/45 (4%)    1/42 (2%)    0/39 (0%)   |1/40 (3%)    2/34 (6%)    4/37 (11%)   1/41 (2%)    |
|FIRST INCIDENCE    |     661          727 (T)      664          549         |728 (T)      605          728 (T)      728 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.091N     P=0.059N     P=0.142N     P=0.092N    |P=0.494N     P=0.272      P=0.156      P=0.756N     |
|POLY 3             |     P=0.083N     P=0.076N     P=0.151N     P=0.084N    |P=0.513N     P=0.308      P=0.185      P=0.757N     |
|POLY 1.5           |     P=0.082N     P=0.078N     P=0.154N     P=0.083N    |P=0.519N     P=0.308      P=0.183      P=0.759N     |
|POLY 6             |     P=0.085N     P=0.073N     P=0.148N     P=0.086N    |P=0.502N     P=0.304      P=0.188      P=0.754N     |
|LOGISTIC REGRESSION|     P=0.073N     P=0.076N     P=0.159N     P=0.073N    |P=0.514N     P=0.303      P=0.156      P=0.756N     |
|COCH-ARM / FISHERS |     P=0.080N     P=0.080N     P=0.159N     P=0.080N    |P=0.523N     P=0.309      P=0.181      P=0.753N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Malignant Lymphoma: Histiocytic, Lymphocytic, Mixed,                                                                        |
|     NOS, or Undifferentiated Cell Type                                                                                          |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    1/50 (2%)    4/50 (8%)    1/50 (2%)   |7/50 (14%)   10/50 (20%)  8/50 (16%)   6/50 (12%)   |
|POLY-3 ADJUSTED (b)|     2.1%         2.1%         8.4%         2.2%        |14.9%        21.5%        16.7%        12.8%        |
|TERMINAL (d)       |     1/39 (3%)    1/45 (2%)    3/42 (7%)    0/39 (0%)   |4/40 (10%)   7/34 (21%)   4/37 (11%)   4/41 (10%)   |
|FIRST INCIDENCE    |     727 (T)      727 (T)      664          594         |580          650          524          673          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.508      P=0.730N     P=0.203      P=0.753     |P=0.295N     P=0.248      P=0.471      P=0.474N     |
|POLY 3             |     P=0.508      P=0.756N     P=0.186      P=0.756     |P=0.331N     P=0.288      P=0.515      P=0.502N     |
|POLY 1.5           |     P=0.515      P=0.758N     P=0.183      P=0.758     |P=0.335N     P=0.295      P=0.510      P=0.503N     |
|POLY 6             |     P=0.501      P=0.752N     P=0.189      P=0.755     |P=0.322N     P=0.272      P=0.518      P=0.498N     |
|LOGISTIC REGRESSION|     P=0.542      P=0.730N     P=0.182      P=0.734N    |P=0.338N     P=0.290      P=0.459      P=0.504N     |
|COCH-ARM / FISHERS |     P=0.526      P=0.753N     P=0.181      P=0.753N    |P=0.334N     P=0.298      P=0.500      P=0.500N     |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 20
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Benign Tumors                                                                                                               |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     28/50 (56%)  28/50 (56%)  26/50 (52%)  29/50 (58%) |13/50 (26%)  22/50 (44%)  14/50 (28%)  20/50 (40%)  |
|POLY-3 ADJUSTED (b)|     58.1%        57.4%        54.6%        62.0%       |28.1%        46.6%        29.6%        42.7%        |
|TERMINAL (d)       |     22/39 (56%)  25/45 (56%)  25/42 (60%)  25/39 (64%) |12/40 (30%)  15/34 (44%)  12/37 (32%)  18/41 (44%)  |
|FIRST INCIDENCE    |     617          612          707          472         |586          643          610          659          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.373      P=0.328N     P=0.294N     P=0.480     |P=0.299      P=0.021 *    P=0.421      P=0.118      |
|POLY 3             |     P=0.385      P=0.555N     P=0.444N     P=0.427     |P=0.208      P=0.048 *    P=0.526      P=0.103      |
|POLY 1.5           |     P=0.423      P=0.567N     P=0.430N     P=0.459     |P=0.202      P=0.047 *    P=0.515      P=0.100      |
|POLY 6             |     P=0.333      P=0.535N     P=0.475N     P=0.385     |P=0.223      P=0.048 *    P=0.538      P=0.111      |
|LOGISTIC REGRESSION|     P=0.382      P=0.559N     P=0.372N     P=0.435     |P=0.229      P=0.045 *    P=0.532      P=0.116      |
|COCH-ARM / FISHERS |     P=0.471      P=0.580N     P=0.421N     P=0.500     |P=0.203      P=0.046 *    P=0.500      P=0.101      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Malignant Tumors                                                                                                            |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     27/50 (54%)  15/50 (30%)  20/50 (40%)  20/50 (40%) |12/50 (24%)  21/50 (42%)  19/50 (38%)  17/50 (34%)  |
|POLY-3 ADJUSTED (b)|     54.9%        30.9%        40.8%        41.1%       |25.2%        43.5%        38.6%        35.1%        |
|TERMINAL (d)       |     20/39 (51%)  13/45 (29%)  15/42 (36%)  11/39 (28%) |7/40 (18%)   11/34 (32%)  11/37 (30%)  12/41 (29%)  |
|FIRST INCIDENCE    |     501          601          596          502         |580          605          477          401          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.316N     P=0.006N**   P=0.095N     P=0.170N    |P=0.405      P=0.042 *    P=0.104      P=0.235      |
|POLY 3             |     P=0.234N     P=0.013N*    P=0.116N     P=0.121N    |P=0.320      P=0.045 *    P=0.113      P=0.201      |
|POLY 1.5           |     P=0.234N     P=0.012N*    P=0.116N     P=0.120N    |P=0.312      P=0.044 *    P=0.107      P=0.196      |
|POLY 6             |     P=0.229N     P=0.012N*    P=0.115N     P=0.117N    |P=0.329      P=0.044 *    P=0.118      P=0.205      |
|LOGISTIC REGRESSION|     P=0.176N     P=0.014N*    P=0.131N     P=0.078N    |P=0.270      P=0.039 *    P=0.069      P=0.175      |
|COCH-ARM / FISHERS |     P=0.233N     P=0.013N*    P=0.115N     P=0.115N    |P=0.299      P=0.044 *    P=0.097      P=0.189      |
|=================================================================================================================================|
       Date:  05/13/99                           EXPERIMENT: 88007 TEST: 06                                            Page 21
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                   SODIUM NITRITE
                                         Terminal Sacrifice at 104 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     0.0%         0.075%       0.15%        0.30%       |0.0%         0.075%       0.15%        0.30%        |
|                   |                                                        |                                                    |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Malignant and Benign Tumors                                                                                                 |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     40/50 (80%)  35/50 (70%)  36/50 (72%)  38/50 (76%) |21/50 (42%)  33/50 (66%)  31/50 (62%)  32/50 (64%)  |
|POLY-3 ADJUSTED (b)|     80.5%        71.1%        73.5%        76.8%       |44.0%        67.4%        63.0%        65.6%        |
|TERMINAL (d)       |     30/39 (77%)  31/45 (69%)  31/42 (74%)  28/39 (72%) |16/40 (40%)  20/34 (59%)  22/37 (60%)  25/41 (61%)  |
|FIRST INCIDENCE    |     501          601          596          472         |580          605          477          401          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.469      P=0.063N     P=0.162N     P=0.461N    |P=0.156      P=0.012 *    P=0.037 *    P=0.052      |
|POLY 3             |     P=0.479N     P=0.196N     P=0.279N     P=0.423N    |P=0.054      P=0.015 *    P=0.045 *    P=0.024 *    |
|POLY 1.5           |     P=0.473N     P=0.192N     P=0.262N     P=0.417N    |P=0.050      P=0.014 *    P=0.041 *    P=0.023 *    |
|POLY 6             |     P=0.487N     P=0.193N     P=0.304N     P=0.425N    |P=0.060      P=0.017 *    P=0.048 *    P=0.028 *    |
|LOGISTIC REGRESSION|     P=0.454N     P=0.181N     P=0.242N     P=0.370N    |P=0.045 *    P=0.013 *    P=0.033 *    P=0.023 *    |
|COCH-ARM / FISHERS |     P=0.467N     P=0.178N     P=0.241N     P=0.405N    |P=0.047 *    P=0.013 *    P=0.036 *    P=0.022 *    |
|=================================================================================================================================|

(a)  Number of tumor-bearing animals /  number of animals examined at site.
(b)  Poly-3 adjusted lifetime tumor incidence.
(d)  Observed incidence at terminal kill.
(f)  Beneath the control incidence are the P-values associated with the trend 
test.  Beneath the dosed group incidence are the P-values corresponding to 
pairwise comparisons between the controls and that dosed group.  The life
table analysis regards tumors in animals dying prior to  terminal kill as
 being (directly or indirectly) the cause of death.
Logistic regression is an alternative
 method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage
and Fishers exact tests compare directly the overall incidence rates
For all tests a negative trend is indicated by N
(e)  Value of Statistic cannot be computed.
(I)  Interim sacrifice
(T)  Terminal sacrifice
#   Tumor rates based on number of animals necropsied.
*   To the right of any statistical result, indicates significance at (P<=0.05).
**  To the right of any statistical result, indicates significance at (P<=0.01).